High Tide (NASDAQ: HITI) stock surged 13.11% on Tuesday following strong Q2 earnings with record revenue of $130.7 million (up from $96.9 million YoY) and adjusted earnings of 1 cent per share versus a 3-cent loss a year prior. The cannabis retailer also announced the acquisition of four Northern Helm stores in Ontario for approximately 7.74 million Canadian dollars and secured a new 40 million Canadian dollar credit facility from Bank of Montreal.

High Tide Inc. has secured credit approval from Bank of Montreal for C$40 million in new senior secured credit facilities, consisting of a C$25 million revolving facility and a C$15 million delayed draw term loan. The new facilities will replace the company's existing senior credit facility and provide lower-cost capital for growth initiatives. Closing is expected within approximately 30 days.

High Tide Inc. (NASDAQ: HITI) announced it will release its second fiscal quarter 2026 financial and operational results on June 15, 2026, followed by a webcast on June 16, 2026 with CEO Raj Grover and CFO Mayank Mahajan. The company also granted 66,500 incentive stock options to employees. High Tide operates Canna Cabana, the largest cannabis retail chain in Canada with 222 domestic locations and a 12% market share, along with medical cannabis distribution operations in Germany.

The global medical marijuana market is experiencing rapid growth driven by legalization, clinical adoption, and institutional investment. The market is projected to reach $130 billion by the early-to-mid 2030s from approximately $26-27 billion in 2026, representing over 20% annual growth. Key drivers include expanding legalization worldwide, pharmaceutical innovation in cannabinoid-based medicines, and new product formats improving accessibility.

High Tide's subsidiary NuLeaf Naturals is pursuing participation in the CMS Innovation Center's Beneficiary Engagement Incentive pilot program, which allows Medicare beneficiaries to receive eligible hemp-derived CBD products at no cost. The program launched on April 1, 2026, and represents a significant opportunity for integration of CBD products into federally supported healthcare models, with potential expansion to additional CMS models beginning January 2027.

Options markets are pricing in elevated post-earnings volatility for 10 stocks reporting this week, with implied moves of 30% or more. The list is dominated by regional banks, with Capitol Federal Financial topping the list. The Federal Reserve's policy decision on Wednesday is expected to magnify price swings.

High Tide Inc. ranked 182nd out of 400 companies in the 2025 Report on Business ranking of Canada's Top Growing Companies, with a three-year revenue growth rate of 188%. The company celebrated its fifth consecutive year of recognition and highlighted its recent majority acquisition of Remexian in the European cannabis market.

High Tide Inc. announced the opening of two new Canna Cabana cannabis retail stores in Saskatoon, Saskatchewan and Lasalle, Ontario, expanding their total store count to 205 locations across Canada.

High Tide reported Q4 revenue of CA$138.3 million, beating estimates, but missed on EPS. The company saw accelerating growth in its membership program and generated positive free cash flow. High Tide expects to remain free cash flow positive for the rest of the fiscal year.

The cannabis industry faces regulatory challenges, including delays in the DEA's reclassification process and scrutiny over enforcement strategies. However, there are also positive developments, such as declines in teen marijuana use in legal states and advancements in medical cannabis research and product innovation.

The article discusses the latest leadership changes in the cannabis industry, including new hires and board appointments at EnWave Corporation, Virpax Pharmaceuticals, Cresco Labs, Avicanna, and High Tide.

Here is how Atyr Pharma (ATYR) and High Tide Inc. (HITI) have performed compared to their sector so far this year.